Skip to main content
Table of Contents
Print

Are There RCTs Showing Cannabis Helps Mood Disorders? 

Author: Dr. Clarissa Morton, PharmD

The evidence from cannabis RCTs is still developing, with only a handful of studies examining how cannabis might help depression, anxiety, or bipolar disorder. While early findings suggest possible benefits for sleep, anxiety reduction, and mood stabilisation, the overall results remain mixed. For those living with mood disorders, cannabis is not yet a first-line treatment due to limited large-scale data. 

Most existing randomised trials for cannabis focus on safety and short-term effects rather than long-term mental health outcomes. This means patients with a mental health condition  still face uncertainty about the reliability of cannabis as part of their treatment plan. 

Evidence From Clinical Research 

Exploring cannabis RCTs involves looking closely at how these trials have been designed and what they have discovered so far. 

Randomised Trials for Cannabis 

Several randomised trials for cannabis suggest CBD may reduce anxiety and improve sleep, indirectly helping with depressive symptoms. However, sample sizes are often small. 

Clinical Trials for Mood Disorders 

Direct clinical trials for mood disorders involving cannabis remain rare. Most research is observational, making it difficult to draw strong conclusions about effectiveness. 

Evidence of Cannabis RCTs 

The current evidence of cannabis RCTs highlights the need for larger, better-controlled studies before cannabis can be recommended widely for mood disorder management. 

In summary, while cannabis RCTs provide early signals of potential benefit, the evidence base is too limited to make strong clinical recommendations. Cannabis may be considered only in specialist settings under close supervision. 

For patients interested in whether cannabis research could inform their treatment, providers like LeafEase can offer professional consultations to ensure safe and personalised care. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Mood Disorders. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories